Compare AbCellera Biologics Inc (ABCL) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Kinder Morgan Inc — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Kinder Morgan Inc trades at $32.48 (market cap $72.28B). The key difference: Kinder Morgan Inc is far larger — about 30.8× AbCellera Biologics Inc's market cap, and Kinder Morgan Inc pays a 3.62% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | KMI | |
|---|---|---|
Market Cap | $2.35B | $72.28B |
Sector | Health | Energy |
52-Week High | $8.12 | $34.31 |
52-Week Low | $2.78 | $25.84 |
Enterprise Value | $1.99B | $104.16B |
Dividend Yield | — | 3.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
